Trial · NCT03265132
Trial comparisons28
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 20 of 28
Download this page as JSON| Comparison | Source |
|---|---|
| Anakinra vs Placebo: Proportion of Responders in Assessment of Physical Function (CHAQ/SHAQ). | Trial comparisons |
| Anakinra vs Placebo: Proportion of Patients With Macrophage Activation Syndrome (MAS). | Trial comparisons |
| Anakinra vs Placebo: Proportion of ACR70 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Patients With Absence of Rash. | Trial comparisons |
| Anakinra vs Placebo: Proportion of ACR90 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Trial comparisons |
| Anakinra vs Placebo: Proportion of ACR50 Responders With Absence of Fever During 7 Days Preceding Week 2. | Trial comparisons |
| Anakinra vs Placebo: Proportion of ACR30 Responders With Absence of Fever Attributable to the Disease During the 7 Days Preceding Week 2. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Responders in Patient/Parent Global Assessment of Overall Well-being. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Patients With Inactive Disease. | Trial comparisons |
| Anakinra vs Placebo: Proportion of ACR70 Responders With Absence of Fever During 7 Days Preceding Week 2. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Patients With Absence of Fever During the 24 Hours Preceding Week 1. | Trial comparisons |
| Anakinra vs Placebo: Proportion of ACR30 Responders With Absence of Fever During 24 Hours Preceding Week 1. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Patients With Antidrug Antibodies (ADA) Against Anakinra. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Patients With Neutralizing Antibodies. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Patients With Absence of Fever During the 7 Days Preceding Week 2. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Patients With at Least One Serious Adverse Event Including Death. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Responders in Physician Global Assessment of Disease Activity. | Trial comparisons |
| Anakinra vs Placebo: Proportion of ACR90 Responders With Absence of Fever During 7 Days Preceding Week 2. | Trial comparisons |
| Anakinra vs Placebo: Proportion of Responders in Number of Joints With Active Arthritis. | Trial comparisons |
| Anakinra vs Placebo: Time to Study Drug Discontinuation for Any Reason. | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03265132/comparisons